Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis.
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OBJECTIVE:
To perform a decision analysis to understand better the implications of 19 potential group B streptococcus screening and treatment strategies.
METHODS:
We searched the literature to locate appropriate articles from which to derive probability estimates. Using decision analysis, we 
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Published on UAB School of Public Health (http://www.soph.uab.edu) rate of neonatal sepsis to 31% of expected with an 18% maternal treatment rate and low total costs; and 3) universal 36-week maternal culture, and treatment of all patients experiencing preterm birth and all culture-positive patients results in 14% of expected neonatal sepsis, with a 27% maternal treatment rate and low total costs.
CONCLUSION:
Given the present state of knowledge, three strategies emerge from this decision analysis as most optimal for the prevention of early-onset neonatal group B streptococcal sepsis: universal treatment, treatment based on risk factors, and treatment based on preterm delivery and 36-week culture status.
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